Edward Melanson
Concepts (358)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Energy Metabolism | 53 | 2025 | 927 | 7.430 |
Why?
| | Exercise | 49 | 2025 | 2086 | 4.550 |
Why?
| | Weight Loss | 27 | 2025 | 783 | 4.310 |
Why?
| | Energy Intake | 30 | 2025 | 506 | 3.340 |
Why?
| | Obesity | 30 | 2025 | 2994 | 2.340 |
Why?
| | Fasting | 9 | 2025 | 283 | 2.100 |
Why?
| | Calorimetry, Indirect | 20 | 2024 | 84 | 2.070 |
Why?
| | Caloric Restriction | 8 | 2025 | 124 | 2.060 |
Why?
| | Thermogenesis | 6 | 2024 | 44 | 1.920 |
Why?
| | Calorimetry | 10 | 2024 | 71 | 1.540 |
Why?
| | Weight Reduction Programs | 6 | 2025 | 118 | 1.510 |
Why?
| | Overweight | 13 | 2025 | 573 | 1.490 |
Why?
| | Adipose Tissue, Brown | 3 | 2024 | 55 | 1.430 |
Why?
| | Breakfast | 2 | 2020 | 20 | 1.320 |
Why?
| | Eating | 12 | 2022 | 394 | 1.260 |
Why?
| | Sleep | 16 | 2024 | 800 | 1.250 |
Why?
| | Dietary Fats | 7 | 2019 | 301 | 1.230 |
Why?
| | Meals | 5 | 2020 | 132 | 1.230 |
Why?
| | Body Composition | 20 | 2025 | 695 | 1.140 |
Why?
| | Accelerometry | 6 | 2025 | 109 | 1.080 |
Why?
| | Resistance Training | 6 | 2024 | 166 | 1.040 |
Why?
| | Oxygen Consumption | 13 | 2025 | 710 | 1.010 |
Why?
| | Diet | 9 | 2025 | 1285 | 0.920 |
Why?
| | Basal Metabolism | 8 | 2024 | 62 | 0.900 |
Why?
| | Walking | 10 | 2025 | 541 | 0.850 |
Why?
| | Circadian Rhythm | 13 | 2024 | 489 | 0.850 |
Why?
| | Gonadotropin-Releasing Hormone | 4 | 2024 | 212 | 0.840 |
Why?
| | Premenopause | 3 | 2020 | 132 | 0.830 |
Why?
| | Adult | 72 | 2025 | 38393 | 0.820 |
Why?
| | Oxygen Isotopes | 5 | 2021 | 23 | 0.820 |
Why?
| | Estradiol | 2 | 2018 | 525 | 0.810 |
Why?
| | Behavior Therapy | 3 | 2021 | 273 | 0.800 |
Why?
| | Monitoring, Physiologic | 6 | 2024 | 280 | 0.800 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2024 | 144 | 0.800 |
Why?
| | Lipid Metabolism | 5 | 2012 | 523 | 0.770 |
Why?
| | Dietary Carbohydrates | 8 | 2019 | 154 | 0.750 |
Why?
| | Humans | 121 | 2025 | 138972 | 0.740 |
Why?
| | Female | 86 | 2025 | 74016 | 0.740 |
Why?
| | Dietary Proteins | 7 | 2019 | 135 | 0.730 |
Why?
| | Water | 4 | 2024 | 461 | 0.730 |
Why?
| | Body Weight | 11 | 2021 | 996 | 0.720 |
Why?
| | Time Factors | 21 | 2025 | 6869 | 0.710 |
Why?
| | Sleep Deprivation | 9 | 2021 | 181 | 0.710 |
Why?
| | Ovary | 3 | 2020 | 223 | 0.680 |
Why?
| | Middle Aged | 46 | 2025 | 33782 | 0.660 |
Why?
| | Body Mass Index | 20 | 2025 | 2390 | 0.650 |
Why?
| | Cancer Survivors | 2 | 2022 | 289 | 0.650 |
Why?
| | Male | 83 | 2025 | 68250 | 0.640 |
Why?
| | Reference Standards | 1 | 2020 | 184 | 0.640 |
Why?
| | Estrogens | 2 | 2024 | 370 | 0.640 |
Why?
| | Exercise Test | 10 | 2024 | 621 | 0.610 |
Why?
| | Weight Gain | 10 | 2024 | 538 | 0.610 |
Why?
| | Exercise Therapy | 4 | 2025 | 440 | 0.600 |
Why?
| | Adipose Tissue, White | 1 | 2018 | 43 | 0.580 |
Why?
| | Exercise Tolerance | 3 | 2025 | 278 | 0.570 |
Why?
| | Arthroplasty, Replacement, Knee | 4 | 2025 | 366 | 0.570 |
Why?
| | Pulmonary Gas Exchange | 2 | 2018 | 124 | 0.570 |
Why?
| | Appetite | 5 | 2025 | 71 | 0.560 |
Why?
| | Young Adult | 25 | 2025 | 13371 | 0.560 |
Why?
| | Fats | 3 | 2009 | 18 | 0.540 |
Why?
| | Physical Exertion | 5 | 2018 | 209 | 0.530 |
Why?
| | Isotope Labeling | 1 | 2017 | 78 | 0.530 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2019 | 193 | 0.490 |
Why?
| | Rest | 4 | 2018 | 123 | 0.480 |
Why?
| | Leuprolide | 1 | 2015 | 21 | 0.470 |
Why?
| | Muscle, Skeletal | 6 | 2014 | 1734 | 0.470 |
Why?
| | Oxidation-Reduction | 11 | 2019 | 1076 | 0.460 |
Why?
| | Autonomic Nervous System Diseases | 2 | 2025 | 32 | 0.430 |
Why?
| | Hunger | 2 | 2021 | 54 | 0.430 |
Why?
| | Cold Temperature | 3 | 2024 | 188 | 0.430 |
Why?
| | Mass Spectrometry | 1 | 2017 | 739 | 0.430 |
Why?
| | Cross-Over Studies | 9 | 2022 | 555 | 0.420 |
Why?
| | Fatty Acids | 3 | 2012 | 445 | 0.380 |
Why?
| | Breast Neoplasms | 2 | 2022 | 2283 | 0.380 |
Why?
| | Monitoring, Ambulatory | 4 | 2017 | 91 | 0.380 |
Why?
| | Parkinson Disease | 3 | 2025 | 557 | 0.370 |
Why?
| | Appetite Regulation | 3 | 2021 | 32 | 0.360 |
Why?
| | Temperature | 1 | 2014 | 660 | 0.360 |
Why?
| | Thinness | 1 | 2012 | 95 | 0.350 |
Why?
| | Deglutition | 5 | 2014 | 71 | 0.350 |
Why?
| | Heart Rate | 7 | 2025 | 801 | 0.340 |
Why?
| | Wearable Electronic Devices | 2 | 2024 | 52 | 0.330 |
Why?
| | Activities of Daily Living | 4 | 2018 | 422 | 0.320 |
Why?
| | Feeding Behavior | 5 | 2025 | 685 | 0.320 |
Why?
| | Perception | 1 | 2013 | 370 | 0.320 |
Why?
| | Melatonin | 5 | 2023 | 154 | 0.310 |
Why?
| | Carbon Dioxide | 2 | 2010 | 241 | 0.310 |
Why?
| | Work Schedule Tolerance | 3 | 2020 | 52 | 0.300 |
Why?
| | Body Weight Maintenance | 2 | 2019 | 16 | 0.300 |
Why?
| | Food | 3 | 2024 | 165 | 0.300 |
Why?
| | Lipid Peroxidation | 1 | 2009 | 152 | 0.290 |
Why?
| | Posture | 5 | 2016 | 192 | 0.280 |
Why?
| | Adaptation, Psychological | 1 | 2013 | 675 | 0.280 |
Why?
| | Reproducibility of Results | 13 | 2023 | 3313 | 0.280 |
Why?
| | Weight Lifting | 2 | 2009 | 32 | 0.270 |
Why?
| | Spectrum Analysis | 3 | 2019 | 91 | 0.260 |
Why?
| | Menopause | 2 | 2022 | 326 | 0.260 |
Why?
| | Anorexia Nervosa | 2 | 2005 | 90 | 0.250 |
Why?
| | Cardiovascular Diseases | 3 | 2024 | 2058 | 0.250 |
Why?
| | Wakefulness | 5 | 2020 | 138 | 0.250 |
Why?
| | Carbohydrate Metabolism | 3 | 2006 | 62 | 0.250 |
Why?
| | Regression Analysis | 4 | 2025 | 1021 | 0.250 |
Why?
| | Metabolic Syndrome | 1 | 2009 | 346 | 0.240 |
Why?
| | Deuterium | 4 | 2021 | 98 | 0.240 |
Why?
| | Shoes | 5 | 2017 | 17 | 0.240 |
Why?
| | Calcium, Dietary | 1 | 2005 | 58 | 0.240 |
Why?
| | Adolescent | 15 | 2025 | 21581 | 0.230 |
Why?
| | Delay Discounting | 1 | 2025 | 27 | 0.230 |
Why?
| | Ghrelin | 5 | 2025 | 36 | 0.220 |
Why?
| | Physical Endurance | 3 | 2009 | 273 | 0.220 |
Why?
| | Mastication | 4 | 2014 | 12 | 0.220 |
Why?
| | Sports Equipment | 1 | 2004 | 9 | 0.220 |
Why?
| | Gastrointestinal Microbiome | 2 | 2023 | 699 | 0.220 |
Why?
| | Eyeglasses | 1 | 2024 | 22 | 0.220 |
Why?
| | Double-Blind Method | 3 | 2019 | 1949 | 0.210 |
Why?
| | Signal Processing, Computer-Assisted | 3 | 2017 | 147 | 0.210 |
Why?
| | Osteoarthritis, Knee | 2 | 2025 | 256 | 0.210 |
Why?
| | Cardiorespiratory Fitness | 2 | 2024 | 57 | 0.200 |
Why?
| | Physical Fitness | 2 | 2013 | 207 | 0.200 |
Why?
| | HIV Integrase | 1 | 2024 | 70 | 0.200 |
Why?
| | Biomarkers | 5 | 2024 | 4095 | 0.200 |
Why?
| | HIV Integrase Inhibitors | 1 | 2024 | 69 | 0.200 |
Why?
| | Motor Activity | 3 | 2019 | 716 | 0.200 |
Why?
| | Positron-Emission Tomography | 1 | 2024 | 304 | 0.190 |
Why?
| | Puberty | 2 | 2014 | 152 | 0.190 |
Why?
| | Insulin Resistance | 4 | 2019 | 1222 | 0.190 |
Why?
| | Peptide YY | 4 | 2025 | 17 | 0.180 |
Why?
| | Circadian Clocks | 2 | 2019 | 56 | 0.180 |
Why?
| | Bone Density | 2 | 2015 | 489 | 0.180 |
Why?
| | Diet, Fat-Restricted | 3 | 2011 | 78 | 0.180 |
Why?
| | France | 1 | 2021 | 37 | 0.180 |
Why?
| | Aging | 2 | 2012 | 1857 | 0.170 |
Why?
| | Analysis of Variance | 6 | 2021 | 1317 | 0.170 |
Why?
| | Bone Remodeling | 1 | 2021 | 77 | 0.170 |
Why?
| | Fruit | 1 | 2021 | 146 | 0.170 |
Why?
| | Diabetes Mellitus | 1 | 2009 | 1068 | 0.170 |
Why?
| | Glucose | 2 | 2024 | 1031 | 0.170 |
Why?
| | Vegetables | 1 | 2021 | 161 | 0.170 |
Why?
| | Aged | 15 | 2025 | 24172 | 0.160 |
Why?
| | Nitrogen | 2 | 2012 | 165 | 0.160 |
Why?
| | Starch | 1 | 2019 | 22 | 0.160 |
Why?
| | Contraceptive Agents | 1 | 2020 | 66 | 0.160 |
Why?
| | Nutritive Value | 1 | 2019 | 37 | 0.160 |
Why?
| | Cross-Sectional Studies | 6 | 2023 | 5530 | 0.150 |
Why?
| | Sweating | 1 | 2019 | 41 | 0.150 |
Why?
| | Amputees | 1 | 2021 | 97 | 0.150 |
Why?
| | Inpatients | 1 | 2023 | 505 | 0.150 |
Why?
| | Parathyroid Hormone | 1 | 2019 | 111 | 0.150 |
Why?
| | Adipocytes | 2 | 2018 | 227 | 0.140 |
Why?
| | Body Temperature | 2 | 2010 | 223 | 0.140 |
Why?
| | Telerehabilitation | 1 | 2019 | 38 | 0.140 |
Why?
| | Hospitals | 1 | 2023 | 699 | 0.140 |
Why?
| | Proof of Concept Study | 1 | 2018 | 85 | 0.140 |
Why?
| | Adaptation, Physiological | 3 | 2018 | 548 | 0.140 |
Why?
| | Postprandial Period | 3 | 2020 | 110 | 0.140 |
Why?
| | High-Intensity Interval Training | 1 | 2018 | 25 | 0.140 |
Why?
| | Brain Mapping | 3 | 2016 | 523 | 0.140 |
Why?
| | Guideline Adherence | 1 | 2022 | 560 | 0.140 |
Why?
| | Time-to-Treatment | 1 | 2019 | 213 | 0.140 |
Why?
| | Pilot Projects | 5 | 2022 | 1765 | 0.130 |
Why?
| | Artificial Limbs | 1 | 2021 | 205 | 0.130 |
Why?
| | Postmenopause | 1 | 2019 | 376 | 0.130 |
Why?
| | Brain | 4 | 2025 | 2791 | 0.130 |
Why?
| | Diet, Reducing | 3 | 2025 | 91 | 0.130 |
Why?
| | Algorithms | 4 | 2015 | 1730 | 0.130 |
Why?
| | Tachycardia, Ventricular | 1 | 2018 | 172 | 0.130 |
Why?
| | Self Report | 1 | 2021 | 842 | 0.130 |
Why?
| | Computer Storage Devices | 1 | 2016 | 2 | 0.130 |
Why?
| | Gait | 2 | 2017 | 303 | 0.130 |
Why?
| | Odds Ratio | 1 | 2019 | 1084 | 0.130 |
Why?
| | Combined Modality Therapy | 1 | 2019 | 1235 | 0.130 |
Why?
| | Homeostasis | 3 | 2019 | 614 | 0.120 |
Why?
| | Life Style | 2 | 2021 | 484 | 0.120 |
Why?
| | Needs Assessment | 1 | 2018 | 381 | 0.120 |
Why?
| | Estrogens, Conjugated (USP) | 1 | 2015 | 50 | 0.120 |
Why?
| | Microbiota | 1 | 2023 | 760 | 0.120 |
Why?
| | Defibrillators, Implantable | 1 | 2018 | 305 | 0.120 |
Why?
| | Veterans | 5 | 2025 | 1481 | 0.110 |
Why?
| | Metabolomics | 1 | 2020 | 689 | 0.110 |
Why?
| | Sleep Stages | 1 | 2014 | 50 | 0.110 |
Why?
| | Blood Glucose | 4 | 2020 | 2241 | 0.110 |
Why?
| | Skin | 1 | 2019 | 756 | 0.110 |
Why?
| | Triglycerides | 2 | 2019 | 513 | 0.110 |
Why?
| | Leptin | 4 | 2025 | 242 | 0.110 |
Why?
| | Health Status | 1 | 2019 | 823 | 0.100 |
Why?
| | Diet Records | 2 | 2014 | 83 | 0.100 |
Why?
| | Proteome | 1 | 2018 | 471 | 0.100 |
Why?
| | Calcium | 1 | 2019 | 1188 | 0.100 |
Why?
| | Muscle Fatigue | 1 | 2014 | 97 | 0.100 |
Why?
| | Nervous System Physiological Phenomena | 1 | 2013 | 22 | 0.100 |
Why?
| | Cell Phone | 1 | 2014 | 76 | 0.100 |
Why?
| | Task Performance and Analysis | 1 | 2014 | 191 | 0.100 |
Why?
| | Sound Spectrography | 2 | 2009 | 18 | 0.100 |
Why?
| | Blood Pressure | 1 | 2019 | 1737 | 0.100 |
Why?
| | Surveys and Questionnaires | 3 | 2023 | 5884 | 0.100 |
Why?
| | Urinalysis | 1 | 2012 | 77 | 0.090 |
Why?
| | Insulin | 5 | 2020 | 2447 | 0.090 |
Why?
| | Hydrogen | 1 | 2012 | 75 | 0.090 |
Why?
| | Area Under Curve | 1 | 2013 | 319 | 0.090 |
Why?
| | Lasers | 1 | 2012 | 129 | 0.090 |
Why?
| | Smoking | 1 | 2019 | 1610 | 0.090 |
Why?
| | Hot Temperature | 2 | 2018 | 392 | 0.090 |
Why?
| | Adipose Tissue | 3 | 2011 | 645 | 0.090 |
Why?
| | Case-Control Studies | 4 | 2021 | 3574 | 0.090 |
Why?
| | Aged, 80 and over | 5 | 2021 | 7685 | 0.090 |
Why?
| | Magnetic Resonance Imaging | 4 | 2025 | 3636 | 0.090 |
Why?
| | Sex Factors | 2 | 2014 | 2050 | 0.090 |
Why?
| | Heart Failure | 1 | 2024 | 2065 | 0.080 |
Why?
| | Nerve Net | 1 | 2013 | 268 | 0.080 |
Why?
| | Physical Phenomena | 1 | 2010 | 13 | 0.080 |
Why?
| | Prospective Studies | 5 | 2021 | 7661 | 0.080 |
Why?
| | Muscle Proteins | 1 | 2012 | 239 | 0.080 |
Why?
| | Chronic Disease | 3 | 2024 | 1804 | 0.080 |
Why?
| | Collagen Type I | 2 | 2021 | 139 | 0.080 |
Why?
| | Glycerol | 1 | 2009 | 91 | 0.080 |
Why?
| | Diet Surveys | 1 | 2009 | 95 | 0.080 |
Why?
| | Somatotypes | 1 | 2009 | 4 | 0.080 |
Why?
| | Pattern Recognition, Automated | 1 | 2009 | 73 | 0.080 |
Why?
| | Cues | 1 | 2011 | 319 | 0.080 |
Why?
| | Models, Biological | 3 | 2018 | 1810 | 0.080 |
Why?
| | Spirometry | 1 | 2010 | 263 | 0.080 |
Why?
| | Thermography | 1 | 2009 | 11 | 0.080 |
Why?
| | Validation Studies as Topic | 1 | 2009 | 21 | 0.080 |
Why?
| | Nutritional Requirements | 2 | 2024 | 81 | 0.070 |
Why?
| | HIV Infections | 1 | 2024 | 2945 | 0.070 |
Why?
| | Auscultation | 1 | 2008 | 4 | 0.070 |
Why?
| | Age Factors | 2 | 2007 | 3276 | 0.070 |
Why?
| | Kinetics | 1 | 2012 | 1649 | 0.070 |
Why?
| | Cerebral Cortex | 1 | 2011 | 452 | 0.070 |
Why?
| | Healthy Volunteers | 2 | 2019 | 208 | 0.070 |
Why?
| | Respiratory Function Tests | 1 | 2010 | 561 | 0.070 |
Why?
| | Dietary Supplements | 1 | 2012 | 559 | 0.070 |
Why?
| | Colorado | 3 | 2021 | 4543 | 0.070 |
Why?
| | Body Fat Distribution | 1 | 2007 | 50 | 0.070 |
Why?
| | Phosphorylation | 1 | 2012 | 1767 | 0.070 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2007 | 158 | 0.060 |
Why?
| | Norepinephrine | 1 | 2007 | 192 | 0.060 |
Why?
| | Rats, Wistar | 4 | 2011 | 453 | 0.060 |
Why?
| | Reference Values | 2 | 2012 | 801 | 0.060 |
Why?
| | Sensitivity and Specificity | 3 | 2012 | 1939 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2021 | 2516 | 0.060 |
Why?
| | Patient Selection | 1 | 2009 | 680 | 0.060 |
Why?
| | Animals | 7 | 2019 | 37243 | 0.060 |
Why?
| | Gene Expression Regulation | 2 | 2012 | 2591 | 0.060 |
Why?
| | Dairy Products | 1 | 2005 | 35 | 0.060 |
Why?
| | Telemedicine | 2 | 2025 | 876 | 0.060 |
Why?
| | Recovery of Function | 2 | 2025 | 665 | 0.060 |
Why?
| | Transcription, Genetic | 1 | 2012 | 1471 | 0.060 |
Why?
| | Photoperiod | 2 | 2019 | 54 | 0.060 |
Why?
| | Polysomnography | 2 | 2020 | 207 | 0.060 |
Why?
| | Gyrus Cinguli | 1 | 2025 | 93 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2022 | 1522 | 0.060 |
Why?
| | Parasympathetic Nervous System | 1 | 2004 | 28 | 0.060 |
Why?
| | Clinical Trials as Topic | 1 | 2009 | 1034 | 0.060 |
Why?
| | Shift Work Schedule | 1 | 2024 | 12 | 0.050 |
Why?
| | Equipment Design | 2 | 2017 | 518 | 0.050 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2004 | 56 | 0.050 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2025 | 140 | 0.050 |
Why?
| | Long QT Syndrome | 1 | 2005 | 67 | 0.050 |
Why?
| | Thrombophilia | 1 | 2024 | 86 | 0.050 |
Why?
| | Statistics as Topic | 1 | 2004 | 299 | 0.050 |
Why?
| | Impulsive Behavior | 1 | 2025 | 152 | 0.050 |
Why?
| | Adiposity | 3 | 2016 | 522 | 0.050 |
Why?
| | Adiponectin | 1 | 2025 | 240 | 0.050 |
Why?
| | Walk Test | 1 | 2023 | 80 | 0.050 |
Why?
| | Linear Models | 2 | 2018 | 855 | 0.050 |
Why?
| | Reaction Time | 1 | 2025 | 421 | 0.050 |
Why?
| | Integrases | 1 | 2024 | 121 | 0.050 |
Why?
| | Anaerobic Threshold | 1 | 2002 | 28 | 0.050 |
Why?
| | Sampling Studies | 1 | 2002 | 101 | 0.050 |
Why?
| | Sensation | 1 | 2022 | 56 | 0.050 |
Why?
| | Blood Coagulation | 1 | 2024 | 262 | 0.050 |
Why?
| | Hormones | 2 | 2016 | 141 | 0.050 |
Why?
| | Prefrontal Cortex | 1 | 2025 | 306 | 0.050 |
Why?
| | Electromyography | 2 | 2014 | 400 | 0.050 |
Why?
| | Self-Management | 1 | 2024 | 186 | 0.050 |
Why?
| | Women's Health | 1 | 2004 | 372 | 0.050 |
Why?
| | Satiation | 1 | 2021 | 28 | 0.050 |
Why?
| | Recurrence | 2 | 2019 | 1085 | 0.040 |
Why?
| | Osteocalcin | 1 | 2021 | 38 | 0.040 |
Why?
| | Craving | 1 | 2021 | 37 | 0.040 |
Why?
| | Perimenopause | 1 | 2022 | 65 | 0.040 |
Why?
| | Waist Circumference | 1 | 2021 | 140 | 0.040 |
Why?
| | Muscle Strength | 1 | 2024 | 320 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2025 | 416 | 0.040 |
Why?
| | Proteins | 2 | 2006 | 1009 | 0.040 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2021 | 131 | 0.040 |
Why?
| | Absorptiometry, Photon | 2 | 2016 | 263 | 0.040 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 16 | 0.040 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 26 | 0.040 |
Why?
| | Rats | 4 | 2011 | 5591 | 0.040 |
Why?
| | Disability Evaluation | 1 | 2021 | 299 | 0.040 |
Why?
| | Bone Resorption | 1 | 2019 | 85 | 0.040 |
Why?
| | Health Behavior | 1 | 2024 | 780 | 0.040 |
Why?
| | Decision Trees | 1 | 2018 | 82 | 0.040 |
Why?
| | Mathematical Concepts | 1 | 2018 | 32 | 0.040 |
Why?
| | Acidosis | 1 | 2019 | 101 | 0.040 |
Why?
| | Patient Discharge | 1 | 2025 | 915 | 0.040 |
Why?
| | Feces | 1 | 2021 | 481 | 0.040 |
Why?
| | Single-Blind Method | 1 | 2019 | 286 | 0.040 |
Why?
| | Humidity | 1 | 2018 | 46 | 0.040 |
Why?
| | Methanol | 1 | 2018 | 43 | 0.030 |
Why?
| | Solvents | 1 | 2018 | 112 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2022 | 980 | 0.030 |
Why?
| | Treatment Outcome | 3 | 2018 | 10921 | 0.030 |
Why?
| | Research Design | 1 | 2024 | 1120 | 0.030 |
Why?
| | Health Promotion | 1 | 2023 | 750 | 0.030 |
Why?
| | Europe | 1 | 2018 | 407 | 0.030 |
Why?
| | Wrist | 1 | 2017 | 57 | 0.030 |
Why?
| | Sex Characteristics | 1 | 2002 | 766 | 0.030 |
Why?
| | Lower Extremity | 1 | 2021 | 434 | 0.030 |
Why?
| | Plasma | 1 | 2018 | 220 | 0.030 |
Why?
| | Materials Testing | 1 | 2018 | 350 | 0.030 |
Why?
| | Methods | 1 | 1996 | 68 | 0.030 |
Why?
| | Maximal Voluntary Ventilation | 1 | 2016 | 9 | 0.030 |
Why?
| | Self Disclosure | 1 | 1996 | 65 | 0.030 |
Why?
| | Equipment and Supplies | 1 | 1996 | 42 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2021 | 2030 | 0.030 |
Why?
| | Proteomics | 1 | 2022 | 1112 | 0.030 |
Why?
| | Carbon Isotopes | 1 | 1996 | 140 | 0.030 |
Why?
| | Smartphone | 1 | 2016 | 89 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2016 | 366 | 0.030 |
Why?
| | Nontherapeutic Human Experimentation | 1 | 2014 | 4 | 0.030 |
Why?
| | Disease Models, Animal | 3 | 2011 | 4316 | 0.030 |
Why?
| | Support Vector Machine | 1 | 2014 | 37 | 0.030 |
Why?
| | Child | 3 | 2024 | 21936 | 0.030 |
Why?
| | Peptides | 1 | 2019 | 980 | 0.030 |
Why?
| | Logistic Models | 1 | 2018 | 2093 | 0.030 |
Why?
| | Risk Factors | 2 | 2020 | 10385 | 0.030 |
Why?
| | Machine Learning | 1 | 2018 | 516 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2023 | 15901 | 0.020 |
Why?
| | Interviews as Topic | 1 | 1996 | 805 | 0.020 |
Why?
| | Bicycling | 1 | 2013 | 114 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 1031 | 0.020 |
Why?
| | Anabolic Agents | 1 | 2012 | 12 | 0.020 |
Why?
| | Sleep Wake Disorders | 1 | 2015 | 301 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2016 | 748 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1473 | 0.020 |
Why?
| | United States | 2 | 2020 | 15074 | 0.020 |
Why?
| | Muscle Contraction | 1 | 2014 | 432 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2019 | 2815 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2015 | 2047 | 0.020 |
Why?
| | Biomechanical Phenomena | 1 | 2014 | 817 | 0.020 |
Why?
| | Transcription Factors | 1 | 2019 | 1701 | 0.020 |
Why?
| | Photic Stimulation | 1 | 2011 | 251 | 0.020 |
Why?
| | Oxygen | 1 | 2016 | 977 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2018 | 2850 | 0.020 |
Why?
| | Geriatric Assessment | 1 | 2012 | 219 | 0.020 |
Why?
| | Models, Theoretical | 1 | 2014 | 581 | 0.020 |
Why?
| | Fourier Analysis | 1 | 2009 | 41 | 0.020 |
Why?
| | Hydrostatic Pressure | 1 | 2009 | 30 | 0.020 |
Why?
| | Electric Impedance | 1 | 2009 | 111 | 0.020 |
Why?
| | Cognition | 1 | 2016 | 1179 | 0.020 |
Why?
| | Body Height | 1 | 2009 | 197 | 0.020 |
Why?
| | Arrhythmias, Cardiac | 1 | 2005 | 328 | 0.010 |
Why?
| | Mental Recall | 1 | 2003 | 207 | 0.010 |
Why?
| | Mice | 1 | 2019 | 17828 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2005 | 2849 | 0.010 |
Why?
|
|
Melanson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|